Pharmaceutical Composition, Dry Powder Layering of Zafirlukast on Non-Pareils, US Patent 6,399,104.
Pharmaceutical Composition, Stabilization of Rosuvastatin by a Multivalent Cationic Tribasic Phosphate Salt, US Patent 6,316,460.
Pharmaceutical Composition, Stabilization of Rosuvastatin by Multivalent Cations, US Patent 6,548,513.
Crystalline Forms of 11-piperazin-l-yl dibenzo[b,f] [1 ,4]thiazepine (AZD7325), US Patient 8,389,510.
Pharmaceutical Composition, Stabilization of Rosuvastatin as Part of a Dosage Form Coating, US Patent 10,028,953.
Pharmaceutical Composition, Stabilization of Rosuvastatin Calcium in a Coating System Sprayed on to Solid Dosage Forms, US Patent 8,632,807.
Pharmaceutical Compositions Comprising HMG CoA Reductase Inhibitor, Photoprotection of Rosuvastatin Tablets, NZ Patent 531474.
Solid Formulation, Solid Formulations of AZD7325, US Patent Application 20090215744.
Liquid Formulation, Liquid Formulations of AZD7325, US Patent Application 20090069292.
Creekmore Pharma Consulting
101 Winterbury Lane Wilmington Delaware 19808 United States
Copyright © 2020 Creekmore Pharma Consulting - All Rights Reserved.
Powered by GoDaddy Website Builder